Watch the recording below!

Why does having patient-centric and inclusive trials even matter? Ask Oswald, one of the FIRST patients to benefit from a cutting edge immunotherapy treatment.

Hear from him and his doctor, Dr. Catherine Ann Shu, on why testing and releasing new therapies that work for *all* matters so much -- and what the stakes are if we keep leaving out people of color from trials.